Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model

Chimeric antigen receptor (CAR) T cell therapy faces a number of challenges for the treatment of non-small-cell lung carcinoma (NSCLC), and efficient migration of circulating CAR T cells plays an important role in anti-tumor activity. In this study, a CAR specific for tumor antigen mesothelin (Msln-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanan, Wang, Jing, Yang, Xinyi, Yang, Jinlong, Lu, Panpan, Zhao, Lin, Li, Bokang, Pan, Hanyu, Jiang, Zhengtao, Shen, Xiaoting, Liang, Zhiming, Liang, Yue, Zhu, Huanzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992009/
https://www.ncbi.nlm.nih.gov/pubmed/33777013
http://dx.doi.org/10.3389/fimmu.2021.628906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992009/
https://www.ncbi.nlm.nih.gov/pubmed/33777013
http://dx.doi.org/10.3389/fimmu.2021.628906

Ejemplares similares